← All companies
CV

Cathay Venture

Cathay Financial's evergreen venture arm, investing seed to pre-IPO in deep tech, biotech and fintech.

🇹🇼 Taipei, Taiwan · Founded 2003

Seed to Growth

VC / FundAI infrastructureSemiconductorsRoboticsBiotechnologyHealthcare
Ask for an introduction

Cathay Venture Inc. is the venture capital arm of Cathay Financial Holdings, Taiwan's largest financial holding company by assets. It was founded in April 2003 and is based in Taipei. It runs as an evergreen fund and invests in unlisted companies at all stages, from seed to pre-IPO. It says it has invested in more than 400 companies. Its overseas focus covers Taiwanese companies abroad, technology in the U.S., Europe and Japan, and growth markets in Southeast Asia.

What they invest in

We invest in unlisted companies with growth potential, at all stages from seed to pre-IPO. Our focus is frontier technology, biotechnology and healthcare, fintech, and high-quality overseas deals.

Stage
Seed to Growth
Fund
Evergreen fund
Sectors
  • AI infrastructure
  • Semiconductors
  • Robotics
  • Biotechnology
  • Healthcare
Regions
  • Taiwan
  • United States
  • Europe
  • Japan
  • Southeast Asia

How to pitch

Intro via Openfor

Openfor introduces founders whose company fits the criteria above.

Ask for an introduction

Open to

The firm has no pitch form. Its page on the Cathay Financial Holdings site lists a general email (80357826@cathaycapital.com.tw), a phone number (886-2-77119889) and its Taipei address.

Portfolio

Cathay Venture says it has invested in more than 400 companies since 2003, from seed to pre-IPO. Recent named deals are in semiconductors, AI infrastructure, health tech, logistics and electric vehicles, across Taiwan, Southeast Asia, Europe and North America.

Some of the companies they have backed

SSiPearlEuropean high-performance, low-power processors for supercomputing and AI🇫🇷 Semiconductors · Series A · 2025
HHealth2SyncExitedDigital chronic disease management platform; IPO in 2025🇹🇼 Digital health · Series C+ · 2025
A(aetherAI (雲象科技)ExitedDigital pathology imaging and AI-assisted diagnosis; IPO in 2026Medical AI
MMIMETASExitedOrgan-on-chip tissue models for drug discovery; Bruker took majority in 2026🇳🇱 Biotechnology · Series B · 2018
RTRani TherapeuticsExitedRaised a $53M Series D in 2018; IPO in 2021Biotechnology · Series C+ · 2018

The portfolio at a glance · 14 companies · 2018–2026 · 5 exits

Sectors

  • Biotechnology14%
  • Medical AI14%
  • AI infrastructure7%
  • Digital health7%
  • Other50%

Stage when they invested

  • Series A29%
  • Series B21%
  • Series C+14%

Where the companies are

  • 🇹🇼 Taiwan14%
  • 🇨🇦 Canada7%
  • 🇫🇷 France7%
  • 🇭🇰 Hong Kong7%
  • Other29%

14 investments found in press and public databases, as of Oct 2026. The firm reports 400+ since 2003 and publishes no portfolio list.

Every company, with the details, is on their own site.Full portfolio on www.cathayholdings.com ↗

Co-investors and partners

Funds that invested in the same rounds.

Co-investors in recent rounds

8
Taiwania Capital
BDC Capital
EIC Fund
Rebright Partners
Jungle Ventures
WI Harper Group
AC Ventures
Pegatron Venture Capital

Track record

Updated Oct 2026
400+Companies invested in since 2003
10Exits tracked by CB Insights
27%+Portfolio in semiconductors and electronics (2025)

With Openfor

1 session

Partners and team